Yujie Peng

No ORCID on file · 4 papers in corpus · active 2024-2026

Study types

  • article 1
  • other 1
  • peer-review 1
  • review 1

Condition tags

  • endometriosis 4
  • adenomyosis 2
  • infertility 1
other 2026
Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair
British journal of pharmacology ·doi:10.1111/bph.70360

BACKGROUND AND PURPOSE: Endometriosis is a chronic, hormone-dependent disorder characterized by ectopic implantation of endometrial tissue, often accompanied by pain and infertility. Although the progesterone receptor modulator RU486 is eff…

peer-review 2024
Author response for "Emerging Bioengineering Breakthroughs in Precision Diagnosis and Therapy for Endometriosis and Adenomyosis"
·doi:10.1039/d4tb01755b/v2/response1
review 2024
Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis
Journal of materials chemistry. B ·doi:10.1039/d4tb01755b

Endometriosis and adenomyosis are debilitating gynecological conditions that severely affect the quality of life of women. Traditional diagnostic and treatment methods, including laparoscopic surgery and hormonal therapy, face significant l…

article 2024
Treatment of endometriosis with mifepristone mediated by nanostructured lipid carriers
Drug delivery and translational research ·doi:10.1007/s13346-024-01661-3

Mifepristone, a progesterone receptor antagonist, was initially used to terminate early pregnancy. As scientific research advanced, it emerged to be effective in the treatment of various tumors and tumor-like conditions such as endometriosi…